openPR Logo
Press release

Digital Tornado to Drive the Unstable Angina Therapeutics Market

08-09-2022 10:47 AM CET | Health & Medicine

Press release from: Persistence Market Research

Digital Tornado to Drive the Unstable Angina Therapeutics

The Unstable Angina Therapeutics Market is expected to grow on a robust note going forward. With technology spreading its wings throughout, the healthcare vertical is likely to witness an influx of tech-savvy patients, which would call for clinical mobility. With smartphones penetrating all over at an alarming rate, the healthcare vertical would be seeing a blurring of lines as far as geographies are concerned. This trend would contribute towards a centralized healthcare system shortly.

Anti-angina drugs are the therapeutics used in the treatment of angina pectoris. The condition is the result of myocardial ischemia which occurs due to an imbalance between myocardial blood supply and oxygen requirement. It is the symptom of coronary heart disease in which the arteries carrying blood to the heart become narrow or are blocked due to atherosclerosis.

Several diagnostic tests are performed in order to confirm the condition of angina such as ECG, stress test, echocardiogram, nuclear stress test, chest x-ray, blood tests, coronary angiography, CT scan, cardiac MRI, etc. Anti-angina treatment options include lifestyle changes, medications, angioplasty and stenting, or coronary bypass surgery.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/5837

Segmentations-

By Disease Type

Stable Angina
Unstable Angina
Variant Angina

By Drug Type

Aspirin
Nitrates
Beta Blockers
Statins
Calcium Channel Blockers
Ranolazine
Angiotensin-converting enzyme (ACE) inhibitors

By Dosage Form Type

Oral Dosage Forms
Transdermal
Injectable

By Distribution Channel

Retail Pharmacies
Hospital Pharmacies
Drug Stores
Mail Order Pharmacies

By Region

North America
Latin America
Europe
Asia Pacific Excluding China
China
Middle East & Africa

Request For Table of Content@https://www.persistencemarketresearch.com/toc/5837

Nitrates are often used to treat angina as they relax and widen the blood vessels, which allow more blood to flow to the heart muscles. The U.S. FDA has recently approved nitroglycerin sublingual powder "Gonitro" of U.S.-based Espero Pharmaceuticals for acute relief of an angina pectoris attack in 2016.

Beta blockers works by blocking the effects of hormone epinephrine (adrenaline) which causes the heart to beat more slowly and with less force, thus reducing the blood pressure. Combining nitrates with β-blockers is most commonly used to block tachycardia and generating synergetic anti-ischaemic effect.

Oral dosage forms are the most commonly used for the management of angina. This includes normal and extended release tablets & capsules as well as sublingual dosage forms. These drug forms are available as labelled as well as off-labelled medications.

Cardiovascular diseases are the most common cause of deaths globally according to the WHO. Approx. 17.7 million people died from the heart diseases in 2015, representing 31% of all global deaths. High prevalence of ischemic heart disease has been a huge medical and social concern, thus representing a market opportunity for the market players in all the geographies.

Pre-Book Right Now for Exclusive Analyst Support @ https://www.persistencemarketresearch.com/checkout/5837

The trends in the development of anti-angina drugs include the use of synergistic combinations, ongoing clinical trials and other pharmacological developments including novel routes of administration, dosing regimen, etc. Further, clinical trials are being done to find out novel compounds for the treatment of angina capable of improving the quality of patients' life and minimizing the cost of healthcare.

The development of new drugs provides additional therapeutic options in the treatment of stable angina. Increasing competition in the generic version of the medicines is a threat for the market players.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Tornado to Drive the Unstable Angina Therapeutics Market here

News-ID: 2701136 • Views: 173

More Releases from Persistence Market Research

Wound Antiseptics Market Growth to Surge Owing to Increasing Adoption by End-use …
The global Wound Antiseptics Market is all set to witness a CAGR of 3.5% by the year 2032. With digitized communication channels making a beeline to the healthcare vertical, the advanced clinics are into virtual consultation mode, and this scenario is expected to continue even going forward. Regulatory approvals for this type of communication are on the way. Close to 70% of the public hospitals worldwide are being asked to
The Next Decade See Lentiviral Vectors Market Pushed Towards Exponential Advance …
The Lentiviral Vectors Market is slated to grow at a gracious rate of 11.4% by the year 2032. With value-oriented approach being the need of the hour, the healthcare vertical is likely to go the technologically advanced way in the next 10 years. With Big Data, AI comprising these advancements, the healthcare vertical is bound to create greater strides going forward. Lentiviral vectors are gene delivery mechanisms that are produced from
Global Cognitive Decline Market to Exhibit Increased Demand in the Coming Years
Owing to rising demand for non-invasive brain stimulation, the global cognitive decline market was valued at over US$ 2 Bn in 2020, and is expected to exhibit a CAGR of 5.8 % over the forecast period (2021-2031). Cognitive decline is a condition in which the brain does not work as well as it should. According to the Centers of Disease Control and Prevention (CDC) report, the prevalence of cognitive decline in
Demand for Glycan Analysis Market Driven by Shifting Consumer Perceptions and Gr …
Introduction Therapeutic monoclonal antibodies (mAbs) are glycoproteins produced by living cell systems and the process is known as protein glycosylation. The glycan moieties attached to the proteins directly affects in-vivo bioactivity, stability, solubility and metabolic activity of bio therapeutics or biopharmaceutical products. Glycosylation is a post-translational modification and, is a non-template driven enzymatic modification process. Its structure largely depends up on production methods and conditions. Due to this reason the product can

All 5 Releases


More Releases for Angina

Angina Pectoris Drugs Market Set for Rapid Growth
Global Angina Pectoris Drugs Market: Overview The demand within the global market for angina pectoris drugs has been rising on account of the focus given on treating medical conditions suffered by the geriatric population. The presence of a seamless industry for healthcare diagnostic and treatment has played a major role in market growth. Angina pectoris is a type of chest pain that is triggered due to reduced blood flow to
Refractory Angina Market accentuating the growth 2025
Global Refractory Angina Market: Snapshot In simple terms, refractory angina (RFA) is a disabling chronic heart pain, as a result of heart disease. Angioplasty, coronary artery bypass surgery, or even medical therapy have failed to control this chest pain. A chronic chest pain can be determined if it occurs longer than three months. The blockage of arteries takes place due to a build-up of plaque. As a result, blood flow slows
Angina (Angina Pectoris) Key Players - Angionetics Inc, Hemostemix Inc, and ID P …
Angina (Angina Pectoris) Overview Angina pectoris is a term that describes chest pain caused by myocardial ischemia. It usually occurs on exertion and is relieved by rest. Angina generally is a symptom of coronary artery disease. In most severe cases, it occurs with minimal effort or at rest. Symptoms include anxiety, increased or irregular heart rate, paleness and cold sweat, and a feeling of doom. Risk factors include smoking, sedentary lifestyle, high
Angina Pectoris Treatment Market - Global Industry Insights, 2025
Angina pectoris is a medical term for chest pain or discomfort, which is caused due to coronary heart disease. Angina pectoris mainly occurs when heart muscle are unable to receive adequate blood. This condition usually occurs when one or more of the heart’s arteries are narrowed or blocked, which is also known as ischemia. Angina pectoris leads to uncomfortable pressure, fullness, squeezing or pain in the center of the chest.
Angina (Angina Pectoris) Pipeline Review, H2 2017
The Report Angina (Angina Pectoris) - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Angina (Angina Pectoris) - Pipeline Review, H2 2017, provides an overview of the Angina (Angina Pectoris) (Cardiovascular) pipeline landscape. Angina pectoris is a term that describes chest pain caused by myocardial ischemia. It usually occurs
Refractory Angina Market: Industry Survey and Outlook 2025
Global Refractory Angina Market: Snapshot In simple terms, refractory angina (RFA) is a disabling chronic heart pain, as a result of heart disease. Angioplasty, coronary artery bypass surgery, or even medical therapy have failed to control this chest pain. A chronic chest pain can be determined if it occurs longer than three months. The blockage of arteries takes place due to a build-up of plaque. As a result, blood flow slows